Back to top

TD Cowen Sticks to Its Buy Rating for Avita Medical (RCEL)

TD Cowen analyst Josh Jennings reiterated a Buy rating on Avita Medical today and set a price target of $12.00. Jennings covers the Healthcare sect...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Avita Medical Inc. (RCEL)